The company has teamed up with Cytel, a firm that specialises in developing innovative technology for adaptive clinical trials, to combine its statistical and computational expertise in this area with ClinPhone's range of clinical technologies, and in doing so, present a joint offering to the industry. ClinPhone said that the new partnership offers sponsors "the combined expertise" of the two organisations in the design, planning and implementation of adaptive and other complex study designs. Adaptive trials are currently a hot topic in the clinical trials industry, as they are seen as a way of accelerating drug development without "breaking the rules." The uptake of such studies is growing at a "rapid pace," being driven by creative statisticians; willing managers and regulators; as well as the existence of new enabling technology - adaptive trials and other novel data-driven approaches are only possible in conjunction with electronic data capture (EDC) and other such technologies, integrated in an overall eclinical solution. Through the use of adaptive study designs, clinical trial sponsors effectively have the flexibility to examine early results of a trial half way through and modify its design in order to improve the chances of a positive result, or cancel the study if it appears ineffective. They are still somewhat of a regulatory grey area and their use has been limited so far, although regulatory attitudes are changing, and it is expected by many that the industry will soon embrace the use of new adaptive methods wherever possible, as their use has the potential to cut the duration and ultimately the cost of clinical trials by one third. As such, ClinPhone is angling itself to capture a dominant spot in this emerging corner of the eclinical technology market. Through its alliance with Cytel, the company plans to tailor adaptive trial solutions to the requirements and objectives of each individual clinical development programme, with a planning and implementation service that includes study design consulting, trial simulations, supplies planning and management, clinical data collection, randomisation, trial supply management, data analysis and reporting. Irving Dark, Cytel's vice president of Clinical Research Services said: "The ClinPhone-Cytel collaboration provides sponsors with the full-service offering needed for successful adaptive clinical trials". Dr Bill Byrom, vice president of Product Strategy and Marketing at ClinPhone added: "Technology plays a central role in delivering these types of studies, and Cytel and ClinPhone together are leading the way in offering integrated services that provide a comprehensive solution for the sponsor wishing to benefit from the power of adaptive trials."